Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information
for clinicians and patients is paramount. There have been a number of reports stating that …

Background Adjuvant trastuzumab significantly improves outcomes for patients with HER2-positive
early breast cancer. The standard treatment duration is 12 months but shorter …

There have been several reports noting anosmia and ageusia as possible symptoms of
COVID-19. This is of particular interest in oncology since patients receiving some cancer …

There has been increasing recognition of the high physical morbidity in patients with severe
mental illness, but little has been written about cancer in these patients. Therefore, we …

Given the immune system's importance for cancer surveillance and treatment, we have
investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some …

PURPOSE: This trial was designed to test the safety and efficacy of a tumor-specific genetic
prodrug activation therapy targeted by use of the human erbB-2 gene promoter. The erbB-2 …

Purpose People living with cancer and haematological malignancies are at an increased
risk of hospitalisation and death following infection with acute respiratory syndrome …

Background Using an updated dataset with more patients and extended follow-up, we further
established cancer patient characteristics associated with COVID-19 death. Methods Data …

Background: There is insufficient evidence to support clinical decision-making for cancer
patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data …